Company Filing History:
Years Active: 2024
Title: Richard Hufstetler: Innovator in Cardiac Treatment Technologies
Introduction
Richard Hufstetler is a notable inventor based in Mason, OH (US). He has made significant contributions to the field of cardiac treatment through his innovative patent. His work focuses on improving methods for treating patients with cardiac arrhythmias, showcasing his dedication to advancing medical technology.
Latest Patents
Hufstetler holds a patent for the "Utilization of synergy EMR and EML to create a COXMAZE3 box lesion with radio frequency." This patent outlines various methods for treating a heart of a patient suffering from cardiac arrhythmia. The methods include dissecting tissue at the inferior aspect of a right inferior pulmonary vein to create an oblique sinus defect, as well as opening spaces between critical heart structures. This innovative approach aims to enhance the effectiveness of cardiac procedures.
Career Highlights
Richard Hufstetler is associated with AtriCure, Inc., a company that specializes in innovative cardiac surgical solutions. His work at AtriCure has allowed him to contribute to the development of advanced technologies that improve patient outcomes in cardiac care. Hufstetler's expertise and dedication to his field have positioned him as a key player in medical innovation.
Collaborations
Throughout his career, Hufstetler has collaborated with esteemed colleagues, including Douglas J. Seith and John T. Wesley. These collaborations have fostered an environment of innovation and have led to the development of groundbreaking techniques in cardiac treatment.
Conclusion
Richard Hufstetler's contributions to cardiac treatment technologies exemplify the impact of innovation in medicine. His patent and work at AtriCure, Inc. reflect his commitment to improving patient care and advancing medical practices.